Bio-Rad Laboratories, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shows how much money the company made and spent in the first half of 2026.
The company is laying off workers and closing offices to save money and improve profits.
Reveals the company's earnings and financial health for the first quarter of 2026.
Gives investors extra details about how the company performed in the first quarter.
Directors can now give more employee stock awards through 2036, extending the program two years.
Provides new information about money the company invested in another company.
Complete overview of the company's full-year 2025 finances, leadership, and compensation details.
Stocky reads Bio-Rad Laboratories, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Bio-Rad Laboratories, Inc.'s most recent tracked filing was a 10-Q on 4 Aug 2026: Quarterly financial report filed for six months ended June 30.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.